About ETISENSE
ETISENSE is a company based in Lyon (France) founded in 2017 by Timothe Flenet and Charles Eynard. ETISENSE has raised $507.98 thousand across 2 funding rounds from investors including EIT Health, Angels Sante and Linksium. ETISENSE offers products and services including DECRO Jacket and Software for Data Analysis. ETISENSE operates in a competitive market with competitors including iRhythm Tech, AliveCor, Asimov, Biotricity and Cellarity, among others.
- Headquarter Lyon, France
- Founders Timothe Flenet, Charles Eynard
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Etisense Sas
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$507.98 K (USD)
in 2 rounds
-
Latest Funding Round
$507.98 K (USD), Seed
Jul 16, 2020
-
Investors
EIT Health
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ETISENSE
ETISENSE offers a comprehensive portfolio of products and services, including DECRO Jacket and Software for Data Analysis.
Non-invasive jacket for monitoring cardiac and respiratory functions in animals.
Tools for analyzing physiological data from telemetry systems.
Funding Insights of ETISENSE
ETISENSE has successfully raised a total of $507.98K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $507.98 thousand completed in July 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ETISENSE
ETISENSE has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include EIT Health, Angels Sante and Linksium.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Linksium is engaged in technology transfer and startup creation.
|
Locked | Locked | Locked | |
|
Health Angels Rhône-Alpes is focused on funding health innovations.
|
Locked | Locked | Locked | |
|
Paris-based healthcare startups are funded by an angel network.
|
Locked | Locked | Locked |
Investor details for ETISENSE
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ETISENSE
Investment portfolio details for ETISENSE
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ETISENSE
Detailed financials for ETISENSE
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Etisense Comparisons
Peer comparison for ETISENSE
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ETISENSE
ETISENSE operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Asimov, Biotricity and Cellarity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
Detailed competitors of ETISENSE
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Etisense
Complete news archive for ETISENSE
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ETISENSE
ETISENSE was founded in 2017 and raised its 1st funding round 2 years after it was founded.
ETISENSE is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Timothe Flenet is the current CEO of ETISENSE. They have also founded this company.
ETISENSE is a funded company, having raised a total of $507.98K across 2 funding rounds to date.
ETISENSE was founded in 2017 in Lyon, France, within the health technology sector. Wearable devices for non-invasive cardiac and respiratory monitoring are created, relying on inductive plethysmography. Proprietary sensors, physiological models, and advanced signal processing are integrated into the technology. Software solutions for data monitoring and analysis are also supplied to support clinical and research applications.
ETISENSE's top competitors include AliveCor, iRhythm Tech and Asimov.
ETISENSE offers DECRO Jacket and Software for Data Analysis.
ETISENSE has 4 investors. Key investors include EIT Health, Angels Sante, Linksium, and Health Angels Rhône-Alpes.